<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hu X</submitter><funding>Swiss National Science Foundation</funding><pagination>6270-6279</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10037331</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>145(11)</volume><pubmed_abstract>An electrochemically driven nickel-catalyzed enantioselective reductive cross-coupling of aryl aziridines with alkenyl bromides has been developed, affording enantioenriched β-aryl homoallylic amines with excellent &lt;i>E&lt;/i>-selectivity. This electroreductive strategy proceeds in the absence of heterogeneous metal reductants and sacrificial anodes by employing constant current electrolysis in an undivided cell with triethylamine as a terminal reductant. The reaction features mild conditions, remarkable stereocontrol, broad substrate scope, and excellent functional group compatibility, which was illustrated by the late-stage functionalization of bioactive molecules. Mechanistic studies indicate that this transformation conforms with a stereoconvergent mechanism in which the aziridine is activated through a nucleophilic halide ring-opening process.</pubmed_abstract><journal>Journal of the American Chemical Society</journal><pubmed_title>Nickel-Catalyzed Enantioselective Electrochemical Reductive Cross-Coupling of Aryl Aziridines with Alkenyl Bromides.</pubmed_title><pmcid>PMC10037331</pmcid><funding_grant_id>184986</funding_grant_id><funding_grant_id>200021_184986/1</funding_grant_id><pubmed_authors>Nevado C</pubmed_authors><pubmed_authors>Hu X</pubmed_authors><pubmed_authors>Cuesta-Galisteo S</pubmed_authors><pubmed_authors>Cheng-Sanchez I</pubmed_authors></additional><is_claimable>false</is_claimable><name>Nickel-Catalyzed Enantioselective Electrochemical Reductive Cross-Coupling of Aryl Aziridines with Alkenyl Bromides.</name><description>An electrochemically driven nickel-catalyzed enantioselective reductive cross-coupling of aryl aziridines with alkenyl bromides has been developed, affording enantioenriched β-aryl homoallylic amines with excellent &lt;i>E&lt;/i>-selectivity. This electroreductive strategy proceeds in the absence of heterogeneous metal reductants and sacrificial anodes by employing constant current electrolysis in an undivided cell with triethylamine as a terminal reductant. The reaction features mild conditions, remarkable stereocontrol, broad substrate scope, and excellent functional group compatibility, which was illustrated by the late-stage functionalization of bioactive molecules. Mechanistic studies indicate that this transformation conforms with a stereoconvergent mechanism in which the aziridine is activated through a nucleophilic halide ring-opening process.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Mar</publication><modification>2025-07-08T03:10:31.144Z</modification><creation>2025-04-07T04:56:04.48Z</creation></dates><accession>S-EPMC10037331</accession><cross_references><pubmed>36881734</pubmed><doi>10.1021/jacs.2c12869</doi></cross_references></HashMap>